Tuesday February 10th, RVC is hosting the 4th Annual Colorado Life Sciences Night at the Denver Metro SBDC building in partnership with the Colorado Bio-Sciences Association.



Meet the Pitching Companies:


VetDC, working closely with Colorado State University’s top-ranked Flint Animal Cancer Center, was established to identify and evaluate novel anti-cancer therapies and advance them rapidly in pets. VetDC is focusing on innovative, cutting-edge programs that were initially designed for humans, but were subsequently found to demonstrate promising benefits in companion animals.

KromaTiD, Inc. provides products and services for mutation detection and disease diagnosis. KromaTiD’s patented dGH™ chromosome imaging platform enables detection of all types of chromosomal rearrangements including previously undetectable cryptic inversions. Launched in 2013, KromaTiD’s research products and services are paving the way to a deeper understanding of genetic diseases, including cancers and developmental disorders.

BioFusionary- Their proprietary magnetic induction technology platform provides tools for medical practitioners to tighten, shape & seal tissues, addressing billion dollar market opportunities in aesthetics & surgery. We’ve commenced sales of our FDA cleared device to physicians in the aesthetics market. Our first product non-invasively tightens & restores tone to skin & supportive tissues with numerous advantages over current energy-based devices.

Siva Therapeutics- Their goal is to develop cancer therapies that are less invasive, safer, more effective, less costly, and more practical than current cancer therapies on the market. Currently, cancer patients face treatments that are invasive, risky, disfiguring, moderately effective at best, and very costly. Siva’s approach is to use SivaRodsTM gold nanorods and infrared light to destroy solid tumors and improve patient health and outcome.


Meet the Colorado Life Sciences Panel:

Gino DiScullio, CEO @ Great Lakes Pharmaceuticals– Gino DiSciullo has over 15 years of operational, business development and financing experience from working with and financing early stage life sciences companies. Since 2010 Gino has served as the chairman of the board of Great Lakes and has been intimately involved with the funding and growth of the company. Gino led the Series B financing of Great Lakes as a Partner at Charter Life Sciences, a venture capital firm located in Silicon Valley where he continues to maintain an affiliation. He earned his degree in pathology from Boston University School of Medicine in 1998.

  Jim Chomas, CEO @ Surefire Medical Inc.- Dr. Chomas received his Bachelor’s of Science in Engineering from Duke University and completed doctoral training at the University of Virginia, investigating the use of ultrasound in breast cancer characterization. He has 12 years experience in developing devices from initial concept through pre-clinical trials and clinical trials, and he has authored 17 patents in medical devices. In five years with Siemens Ultrasound as Senior Engineering Manager, Dr. Chomas led a team of engineers and released six product features. Most recently, Dr. Chomas was the Director of Research at Cabochon, where he led the engineering team in the research, development and pre-clinical testing, which ultimately culminated in a 35-patient clinical trial.

Bill Aldrich, CEO @ Endoshape Inc.- Mr. Aldrich has held executive and engineering positions at Ampex, BioTrack, CVIS, Cartesian Data, CardioThoracic Systems, Integrated Vascular Systems and, most recently, at EndoVx, which he founded and raised $5M in venture financing. Bill brings 28 years in the medical device and magnetic recording industries to EndoShape and has 40+ issued U.S. patents and has over 40 pending applications. He holds a B.S. in Mechanical Engineering from the California Polytechnic State University.

Arlen Meyers, President & CEO @ Society of Physician Entrepreneurs, Moderator- Arlen is a professor of otolaryngology, dentistry, and engineering at the University of Colorado Anschutz Medical campus and President and CEO of the Society of Physician Entrepreneurs at www.sopenet.org . In addition, he created several other medical device companies. His primary research centers around biomedical and health innovation and entrepreneurship and life science technology commercialization.

He was a former Harvard-Macy fellow and in 2010, completed a Fulbright at Kings Business, the commercialization office of technology transfer at Kings College in London. Publications this year include several articles in the Journal of Commercial Biotechnology and co-editor of a bioscience business casebook, “Building the Case for Biotechnology.” “Optical Detection of Cancer”, and ” The Life Science Innovation Roadmap”

He is honored to be named by Modern Healthcare as one of the 50 Most Influential Physician Executives of 2011 and nominated in 2012 and Best Doctors 2013



0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *